J. Jacob

发表

Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study

C. Hennequin, G. Lledo, O. Dupuis, 2008, Oncology.

Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.

D. Pezet, J. Raoul, E. Gamelin, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.

P. Couzigou, M. Ychou, M. Ducreux, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan.

J. Douillard, G. Milano, M. Etienne-Grimaldi, 2012, British journal of clinical pharmacology.

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

S. Lecleire, O. Rigal, P. Michel, 2006, World journal of gastroenterology.

A phase III randomized trial of LV5FU2+CPT-11 vs. LV5FU2 alone in adjuvant high risk colon cancer (FNCLCC Accord02/FFCD9802)

M. Ychou, J. Douillard, Y. Bécouarn, 2005 .

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

J. Raoul, P. Michel, X. Mirabel, 2006, British Journal of Cancer.

VINORELBINE IN EPIDERMOID ESOPHAGEAL

T. Conroy, M. Glabbeke, J. Seitz, 2018 .

Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer.

S. Lecleire, O. Rigal, P. Michel, 2006, Gastroenterologie clinique et biologique.

Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.

T. Conroy, G. Deplanque, J. Metges, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus.

T. Wobbes, B. Baron, P. Michel, 2001, European journal of cancer.

Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial.

O. Dalesio, M. Buyse, N. Duez, 1989, International journal of radiation oncology, biology, physics.

Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.

M. Gignoux, H. Bleiberg, A. Roussel, 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.

P. Rougier, J. Douillard, A. de Gramont, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer

M. Ychou, C. Borel, F. Caroli-Bosc, 2002, Cancer Chemotherapy and Pharmacology.

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer.

L. Collette, T. Conroy, M. Namer, 1997, European journal of cancer.

VINORELBINE IN EPIDERMOID ESOPHAGEAL CARCINOMA 167

T. Conroy, J. Seitz, A. Adenis, 2017 .

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

M. van Glabbeke, T. Conroy, M. Glabbeke, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

Agnès Laplanche, Michel Ducreux, M. Ychou, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

J. Douillard, M. Hebbar, J. Seitz, 2005, British Journal of Cancer.

Digestive and genitourinary sequelae in rectal cancer survivors and their impact on health-related quality of life: Outcome of a high-resolution population-based study.

N. Girard, S. Hervé, V. Bouvier, 2019, Surgery.

5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer.

M. Ducreux, P. Rougier, A. Laplanche, 1997, European journal of cancer.

P h ase I I T rial o f Vinorelbine i n M e tastatic Squam o us C ell E sophageal C arcinoma

T. Conroy, J. Seitz, A. Adenis, 1996 .

Capecitabine (X) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial.

C. Hennequin, G. Lledo, O. Dupuis, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Controlled Clinical Trial for the Treatment of Patients with Inopérable Esophageal Carcinoma: A Study of the EOR TC Gastrointestinal Tract Cancer Coopérative Group

M. Buyse, N. Duez, M. Gignoux, 2016 .